Medivis Inc

General

Total Cases5

Active Cases1

Patents15

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

L3

B

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
04/23/24	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	The following patents were Instituted by PTAB: Patent US11004271 in IPR2023-00042
04/24/23	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	The following patents were Instituted by PTAB: Patent US10945807 in IPR2023-00045
12/07/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	SO ORDERED, re 63 STIPULATION and Order to Stay Case Pending IPR Review filed by Novarad Corp. -- Case Stayed. Signed by Judge Gregory B. Williams on 12/7/22. (ntl) (Entered: 12/07/2022)
12/06/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	STIPULATION to Stay Case Pending IPR Review by Novarad Corp.. (Rahmeier, Thatcher) (Entered: 12/06/2022)
11/30/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	Letter to The Honorable Gregory B. Williams from Thatcher A. Rahmeier regarding Oral Order 58 - re 58 Order,. (Rahmeier, Thatcher) (Entered: 11/30/2022)
11/30/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	Letter to The Honorable Gregory B. Williams from Brian R Lemon, Esq. regarding Oral Order - re 58 Order,. (Lemon, Brian) (Entered: 11/30/2022)
11/29/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	REPLY BRIEF re 51 MOTION to Stay Pending Completion of Inter Partes Reviews filed by Medivis, Inc.. (Attachments: # 1 Exhibit 7-9)(Lemon, Brian) (Entered: 11/29/2022)
11/29/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	ORAL ORDER: By no later than December 1, 2022, the parties shall submit to the Court two (2) courtesy copies of the briefs related to Defendant's Motion to Dismiss (i.e., D.I. 11; D.I. 12; D.I. 15; D.I. 16) with hard tabs for any exhibits. ORDERED by Judge Gregory B. Williams on 11/29/22. (ntl) (Entered: 11/29/2022)
11/17/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	ORAL ORDER: For purposes of analyzing the motion to dismiss based on invalidity pursuant to 35 U.S.C. § 101, IT IS HEREBY ORDERED that, no later than November 30, 2022, each side shall file a one (1) page letter identifying which U.S. Supreme Court or Federal Circuit case(s) it contends is most similar to the patent(s)-at issue. ORDERED by Judge Gregory B. Williams on 11/17/22. (ntl) (Entered: 11/17/2022) ORAL ORDER: For purposes of analyzing the motion to dismiss based on invalidity pursuant to 35 U.S.C. § 101, IT IS HEREBY ORDERED that, no later than November 30, 2022, each side shall file a one (1) page letter identifying which U.S. Supreme Court or Federal Circuit case(s) it contends is most similar to the patent(s)-at issue. ORDERED by Judge Gregory B. Williams on 11/17/22. (ntl) (Entered: 11/17/2022)
11/17/22	Novarad Corp v. Medivis Inc 1:21-CV-01447 ( D. DE )	ORAL ORDER: For purposes of analyzing the motion to dismiss based on invalidity pursuant to 35 U.S.C. Â§ 101, IT IS HEREBY ORDERED that, no later than November 30, 2022, each side shall file a one (1) page letter identifying which U.S. Supreme Court or Federal Circuit case(s) it contends is most similar to the patent(s)-at issue. ORDERED by Judge Gregory B. Williams on 11/17/22. (ntl) (Entered: 11/17/2022) ORAL ORDER: For purposes of analyzing the motion to dismiss based on invalidity pursuant to 35 U.S.C. Â§ 101, IT IS HEREBY ORDERED that, no later than November 30, 2022, each side shall file a one (1) page letter identifying which U.S. Supreme Court or Federal Circuit case(s) it contends is most similar to the patent(s)-at issue. ORDERED by Judge Gregory B. Williams on 11/17/22. (ntl) (Entered: 11/17/2022)